Depression Treatment and Screening in Ovarian Cancer Patients
Sponsor: Lance Armstrong Foundation
Listed as NCT00515372, this PHASE1 trial focuses on Fallopian Tube Cancer and Ovarian Cancer and remains ongoing. Sponsored by Lance Armstrong Foundation, it has been updated 17 times since 2002, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
17 versions recorded-
Mar 2026 — Present [monthly]
Active Not Recruiting PHASE1
-
Oct 2025 — Mar 2026 [monthly]
Active Not Recruiting PHASE1
-
Apr 2025 — Oct 2025 [monthly]
Active Not Recruiting PHASE1
-
Oct 2024 — Apr 2025 [monthly]
Active Not Recruiting PHASE1
-
Sep 2024 — Oct 2024 [monthly]
Active Not Recruiting PHASE1
▶ Show 12 earlier versions
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE1
-
Apr 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE1
-
Oct 2023 — Apr 2024 [monthly]
Active Not Recruiting PHASE1
-
Sep 2022 — Oct 2023 [monthly]
Active Not Recruiting PHASE1
-
Apr 2022 — Sep 2022 [monthly]
Active Not Recruiting PHASE1
-
Jan 2021 — Apr 2022 [monthly]
Active Not Recruiting PHASE1
-
Oct 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE1
-
Feb 2020 — Oct 2020 [monthly]
Active Not Recruiting PHASE1
-
Jun 2019 — Feb 2020 [monthly]
Active Not Recruiting PHASE1
-
Jun 2018 — Jun 2019 [monthly]
Active Not Recruiting PHASE1
-
Feb 2018 — Jun 2018 [monthly]
Active Not Recruiting PHASE1
-
Jan 2017 — Feb 2018 [monthly]
Active Not Recruiting PHASE1
First recorded
Dec 2002
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Lance Armstrong Foundation
- M.D. Anderson Cancer Center
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .